• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Obstet Gynaecol Res . The utility of systemic immune-inflammation index and systemic immune-response index in the prediction of adverse outcomes i

tetano

Editor, Senior Moderator
J Obstet Gynaecol Res


. 2022 Dec 29.
doi: 10.1111/jog.15533. Online ahead of print.
The utility of systemic immune-inflammation index and systemic immune-response index in the prediction of adverse outcomes in pregnant women with coronavirus disease 2019: Analysis of 2649 cases


Atakan Tanacan[SUP] 1 [/SUP], Deniz Oluklu[SUP] 1 [/SUP], Bergen Laleli Koc[SUP] 1 [/SUP], Selcan Sinaci[SUP] 1 [/SUP], Dilek Menekse Beser[SUP] 1 [/SUP], Derya Uyan Hendem[SUP] 1 [/SUP], Muradiye Yildirim[SUP] 1 [/SUP], Bedri Sakcak[SUP] 1 [/SUP], Berhan Besimoglu[SUP] 1 [/SUP], Duygu Tugrul Ersak[SUP] 1 [/SUP], Betul Akgun Aktas[SUP] 1 [/SUP], Esra Gulen Yildiz[SUP] 1 [/SUP], Serpil Unlu[SUP] 2 [/SUP], Ozgur Kara[SUP] 1 [/SUP], Evrim Alyamac Dizdar[SUP] 3 [/SUP], Fuat Emre Canpolat[SUP] 3 [/SUP], İhsan Ates[SUP] 4 [/SUP], Ozlem Moraloglu Tekin[SUP] 5 [/SUP], Dilek Sahin[SUP] 5 [/SUP]



Affiliations

Abstract

Aim: To investigate the association of systemic immune-inflammation index (SII) and systemic immune-response index (SIRI) with adverse perinatal outcomes in pregnant women with coronavirus disease 2019 (COVID-19).
Methods: The cases were divided into (1) the Mild-moderate COVID-19 group (n = 2437) and (2) the Severe-critical COVID-19 group (n = 212). Clinical characteristics, perinatal outcomes, SII (neutrophilXplatelet/lymphocyte), and SIRI (neutrophilXmonocyte/lymphocyte) were compared between the groups. Afterward, SII and SIRI values were compared between subgroups based on pregnancy complications, neonatal intensive care unit (NICU) admission, and maternal mortality. A receiver operator characteristic analysis was performed for the determination of optimal cutoff values for SII and SIRI in the prediction of COVID-19 severity, pregnancy complications, NICU admission, and maternal mortality.
Results: Both SII and SIRI were significantly higher in complicated cases (p < 0.05). Cutoff values in the prediction of severe-critical COVID-19 were 1309.8 for SII, and 2.3 for SIRI. For pregnancy complications, optimal cutoff values were 973.2 and 1.6. Cutoff values of 1045.4 and 1.8 were calculated for the prediction of NICU admission. Finally, cut-off values of 1224.2 and 2.4 were found in the prediction of maternal mortality.
Conclusion: SII and SIRI might be used in combination with other clinical findings in the prediction of poor perinatal outcomes.

Keywords: COVID-19; SII; SIRI; adverse perinatal outcomes; maternal mortality; pregnancy.
 
Back
Top Bottom